Drug name - Xepi
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US6335447 | FERRER INTERNACIONAL | Quinolonecarboxylic acid derivatives or salts thereof |
Nov, 2023
(1 year, 1 month from now) | |
| CN1299356A | FERRER INTERNACIONAL | Phenanthroquinolizidine Ketone Carboxylic Acid Ramification And Its Salt |
Apr, 2019
(3 years ago) | |
| CN1152029C | FERRER INTERNACIONAL | Phenanthroquinolizidine Ketone Carboxylic Acid Ramification And Its Salt |
Apr, 2019
(3 years ago) | |
| IN200000373P2 | FERRER INTERNACIONAL | Quinolonecarboxylic Acid Derivatives Or Salts Thereof |
Apr, 2019
(3 years ago) | |
| IN221166B | FERRER INTERNACIONAL | Quinolonecarboxylic Acid Derivatives Or Salts Thereof |
Apr, 2019
(3 years ago) | |
| EP1070713B1 | FERRER INTERNACIONAL | Quinolonecarboxylic Acid Derivatives Or Salts Thereof |
Apr, 2019
(3 years ago) | |
| EP1070713A1 | FERRER INTERNACIONAL | Quinolonecarboxylic Acid Derivatives Or Salts Thereof |
Apr, 2019
(3 years ago) | |
| EP1070713A4 | FERRER INTERNACIONAL | Quinolonecarboxylic Acid Derivatives Or Salts Thereof |
Apr, 2019
(3 years ago) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9399014 | FERRER INTERNACIONAL | Pharmaceutical topical compositions |
Dec, 2029
(7 years from now) | |
| US9180200 | FERRER INTERNACIONAL | Pharmaceutical topical compositions |
Jan, 2032
(9 years from now) | |
Drugs and Companies using OZENOXACIN ingredient
Treatment: Treatment of impetigo due to staphylococcus aureus or streptococcus pyogenes
Dosage: CREAM;TOPICAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 1% | CREAM;TOPICAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.